Synergy of ER stress and oxidative stress after TBI
Synergy of ER stress and oxidative stress after TBI
批准号:
8696902
负责人:
Raghu VEMUGANTI
金额:
$22.35万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-15 至 2016-09-30
关键词:
AcuteApoptosisApoptoticBCL2L11 geneBrainBrain InjuriesCell DeathCell NucleusCell SurvivalCell physiologyCellsCessation of lifeComplexCytosolEndoplasmic ReticulumEnzymesEukaryotic Initiation FactorsFailureGenesGoalsHomeostasisIndividualInflammationInjuryInositolKnock-outKnockout MiceMaintenanceMediatingModificationMolecular ChaperonesNADPH OxidaseNeurologic DysfunctionsNeuronsOrganOxidative StressPancreasPathway interactionsPeripheralPhosphorylationPhosphotransferasesPlayPreventionProtein BiosynthesisProtein DephosphorylationProteinsReactive Oxygen SpeciesRecoveryRecovery of FunctionRodent ModelRoleSecondary toSignal PathwaySignal TransductionStagingStreamStressSystemTestingTranslationsTraumaTraumatic Brain InjuryUbiquitinUbiquitinationactivating transcription factor 1controlled cortical impacteIF-2 Kinaseendoplasmic reticulum stressinhibitor/antagonistinjuredmortalityneurological recoveryneuroprotectionneurotoxicpreventpromoterprotein foldingprotein misfoldingpublic health relevanceresponsetranscription factortranscription factor CHOP
中文摘要
描述(申请人提供):内质网(ER)的有效运作对于正常的细胞功能是不可或缺的,因为内质网在维持细胞内钙稳态、蛋白质的适当折叠、翻译后修饰和将新生蛋白质运送到不同的目的地方面发挥着重要作用。内质网的任何破坏都会导致一系列复杂的信号通路的激活,这些信号通路从内质网传播到胞浆再到细胞核。这些统称为未折叠蛋白反应(UPR),其目的是补偿损伤并恢复正常的细胞内稳态。虽然有限和短暂的UPR是有益的,但长期或严重的UPR,以及随之而来的内质网应激导致细胞死亡。此外,中枢神经系统的侮辱会导致氧化应激,而氧化应激也是神经毒性的。我们假设在创伤性脑损伤后,内质网应激和氧化应激是巧合的,相互双向增强,协同加剧继发性脑损伤。使用受控皮质撞击伤的啮齿动物模型,我们希望回答以下问题。(1)在脑损伤后,PERK介导的内质网应激途径起什么作用?(2)在脑损伤后,内质网应激与氧化应激是否相关?尤其是由PERK介导的内质网应激和由NADPH氧化酶NOX2调控的氧化应激是否相互影响?(3)敲除/抑制单独的PERK途径限速蛋白eIF2、ATF4和CHOP对脑创伤后氧化应激和神经元损伤有何影响?相反,敲除/抑制NOX2对脑创伤后内质网应激和神经元损伤有何影响?长期目标是了解内质网应激和氧化应激在脑损伤后的相互作用。
英文摘要
DESCRIPTION (provided by applicant): Efficient functioning of the Endoplasmic reticulum (ER) is indispensable for normal cellular functions as ER plays an important role in the maintenance of intracellular Ca2+ homeostasis, proper folding of proteins, post-translation modifications and transport of nascent proteins to different destinies. Any disruption of ER results in the activation of a complex set of signaling pathways that propagate from the ER to the cytosol to the nucleus. These are collectively known as unfolded protein response (UPR), which is aimed to compensate damage and to restore the normal cellular homeostasis. While limited and transient UPR is beneficial, prolonged or severe UPR, and the ensuing ER stress leads to cell death. Furthermore, CNS insults leads to oxidative stress which is also neurotoxic. We hypothesize that following traumatic brain injury (TBI), ER stress and oxidative stress are coincidental, potentiate each other bi-directionally and synergistically exacerbate the secondary brain damage. Using a rodent model of controlled cortical impact injury, we wish to answer the following questions. (1) What is the role of PERK-mediated ER stress pathway after TBI? (2) In the post-injury brain, are ER stress and oxidative stress connected? In particular, if ER stress mediated by PERK and oxidative stress modulated by NADPH oxidase NOX2 influence each other? (3) What is the effect of knocking-out/inhibiting individual rate-limiting proteins of PERK pathway eif2¿, ATF4 and CHOP on oxidative stress and neuronal damage after TBI? Conversely, what is the effect of knocking-out/inhibiting NOX2 on ER stress and neuronal damage after TBI? The long-term goal is to understand the mutual interplay of ER stress and oxidative stress in post-TBI brain damage.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/s12035-014-9029-6
发表时间:
2016-01
期刊:
MOLECULAR NEUROBIOLOGY
影响因子:
5.1
作者:
[Nakka, Venkata Prasuja, Prakash-babu, Phanithi, Vemuganti, Raghu]
通讯作者:
Vemuganti, Raghu
Role of RNAs in post-stroke brain damage
-
批准号:10664336
-
项目类别:
-
资助金额:$61.57万
-
财政年份:2023
-
负责人:Raghu VEMUGANTI
-
依托单位:
Epitranscriptomic regulation by m6A RNA methylation after stroke
-
批准号:10604801
-
项目类别:
-
资助金额:$61.81万
-
财政年份:2023
-
负责人:Raghu VEMUGANTI
-
依托单位:
BLRD Research Career Scientist Award Application
-
批准号:10618195
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Raghu VEMUGANTI
-
依托单位:
miR-21 induced neuroprotection after stroke
-
批准号:10513282
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Raghu VEMUGANTI
-
依托单位:
BLRD Research Career Scientist Award Application
-
批准号:10373075
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Raghu VEMUGANTI
-
依托单位:
Neuroprotection after TBI
-
批准号:10454793
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Raghu VEMUGANTI
-
依托单位:
Neuroprotection after TBI
-
批准号:10158429
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Raghu VEMUGANTI
-
依托单位:
DNA hydroxymethylation and post stroke brain damage
-
批准号:9757829
-
项目类别:
-
资助金额:$41.54万
-
财政年份:2018
-
负责人:Raghu VEMUGANTI
-
依托单位:
DNA hydroxymethylation and post stroke brain damage
-
批准号:10261564
-
项目类别:
-
资助金额:$41.54万
-
财政年份:2018
-
负责人:Raghu VEMUGANTI
-
依托单位:
DNA hydroxymethylation and post stroke brain damage
-
批准号:10001037
-
项目类别:
-
资助金额:$41.54万
-
财政年份:2018
-
负责人:Raghu VEMUGANTI
-
依托单位:
DNA hydroxymethylation and post stroke brain damage
-
批准号:10462714
-
项目类别:
-
资助金额:$41.54万
-
财政年份:2018
-
负责人:Raghu VEMUGANTI
-
依托单位:
Therapeutic Targeting of an lncRNA in Experimental Stroke Using STAIR Criteria
-
批准号:9323794
-
项目类别:
-
资助金额:$42.17万
-
财政年份:2017
-
负责人:Raghu VEMUGANTI
-
依托单位:
Targeting alpha-synuclein after cerebral ischemia as a function of sex and age
-
批准号:9891108
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2017
-
负责人:Raghu VEMUGANTI
-
依托单位:
Role of alpha Synuclein and microRNA 7a in post stroke brain damage
-
批准号:8924344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Raghu VEMUGANTI
-
依托单位:
Role of alpha Synuclein and microRNA 7a in post stroke brain damage
-
批准号:9281538
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Raghu VEMUGANTI
-
依托单位:
LncRNA FosDT mediates ischemic brain damage
-
批准号:9139511
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2015
-
负责人:Raghu VEMUGANTI
-
依托单位:
Combo therapy to curtail oxidative stress after TBI
-
批准号:8735202
-
项目类别:
-
资助金额:$7.45万
-
财政年份:2013
-
负责人:Raghu VEMUGANTI
-
依托单位:
Synergy of ER stress and oxidative stress after TBI
-
批准号:8598653
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2013
-
负责人:Raghu VEMUGANTI
-
依托单位:
Combo therapy to curtail oxidative stress after TBI
-
批准号:8637393
-
项目类别:
-
资助金额:$7.53万
-
财政年份:2013
-
负责人:Raghu VEMUGANTI
-
依托单位:
miRNAs and PPAR-gamma-induced neuroprotection
-
批准号:8338957
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2012
-
负责人:Raghu VEMUGANTI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: